HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

Clinical trial NCT06731504 · RECRUITING

Trial details

NCT number: NCT06731504
Sponsor: Duke University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancy

Start date: 2025-11-12
Primary completion: 2027-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.